<DOC>
	<DOCNO>NCT00723385</DOCNO>
	<brief_summary>The purpose study examine whether oral vitamin D supplementation people inadequate vitamin D concentration low LDL-cholesterol total cholesterol concentration .</brief_summary>
	<brief_title>Effects Vitamin D Lipids</brief_title>
	<detailed_description>Data previous trial suggest protective role vitamin D cardiovascular disease . A recent meta-analysis trial least 5 year follow-up vitamin D supplementation conclude intake vitamin D supplement may decrease total mortality , relationship baseline vitamin D status , dose vitamin D supplement , total mortality rate remain investigated . An even recent analysis vitamin D concentration find participant vitamin D deficiency hypertension twice likely people without hypertension vitamin D deficiency cardiovascular event study . The main hypothesis test normalization vitamin D level low LDL-cholesterol total cholesterol concentration people inadequate vitamin D concentration determine circulate 25-OH vitamin D. Subhypotheses HDL-cholesterol , triglyceride , lipoprotein ( ) , hs C-reactive protein Hemoglobin A1c affect , cyp3a-metabolized medication level decrease vitamin D replacement . This 12-week randomized double-blind dose titration study effect supplementation 1000-2000 IU vitamin D lipid vitamin D concentration . Dietary intake vitamin D estimate dietary recall questionnaire analysis three non-consecutive 24-hour dietary intake log .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Any medically stable person able swallow pill Inadequate vitamin D status screen visit Clinical instability underlie disease process ( e.g. , recent hospitalization , change dosage medication within prior two week , new medication within one month ) Recent transfusion Severe renal failure dialysis Hypercalcemia Malignancy active treatment Feeding tube Intestinal bypass surgery Inability swallow tablet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>cholesterol</keyword>
	<keyword>LDL-cholesterol</keyword>
	<keyword>cholecalciferol</keyword>
	<keyword>lipid</keyword>
	<keyword>C-reactive protein</keyword>
</DOC>